CardieX Limited (CDX.AX)
AUD 0.09
(-14.55%)
AUD 0.09
(-14.55%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | - AUD | 0.0% |
| 2023 | 483.09 Thousand AUD | -25.57% |
| 2022 | 649.09 Thousand AUD | 422.8% |
| 2021 | 124.15 Thousand AUD | -89.21% |
| 2020 | 1.15 Million AUD | 6.11% |
| 2019 | 1.08 Million AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| 2006 | - AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q4 | - AUD | 0.0% |
| 2024 Q1 | 2.62 Million AUD | 0.0% |
| 2024 Q3 | - AUD | -100.0% |
| 2024 FY | - AUD | -100.0% |
| 2024 Q2 | 2.21 Million AUD | 0.0% |
| 2023 FY | 483.09 Thousand AUD | -25.57% |
| 2023 Q4 | 483.09 Thousand AUD | 0.0% |
| 2023 Q2 | 572.53 Thousand AUD | 0.0% |
| 2023 Q1 | 572.53 Thousand AUD | -11.79% |
| 2023 Q3 | 483.09 Thousand AUD | -15.62% |
| 2022 FY | 649.09 Thousand AUD | 422.8% |
| 2022 Q2 | 679.94 Thousand AUD | 0.0% |
| 2022 Q3 | 649.09 Thousand AUD | -4.54% |
| 2022 Q4 | 649.09 Thousand AUD | 0.0% |
| 2022 Q1 | 679.94 Thousand AUD | 447.65% |
| 2021 Q2 | 121.65 Thousand AUD | 0.0% |
| 2021 FY | 124.15 Thousand AUD | -89.21% |
| 2021 Q4 | 124.15 Thousand AUD | 14.65% |
| 2021 Q3 | 108.29 Thousand AUD | -10.98% |
| 2021 Q1 | 121.65 Thousand AUD | -89.43% |
| 2020 Q4 | 1.15 Million AUD | 0.0% |
| 2020 Q2 | 237.15 Thousand AUD | -51.16% |
| 2020 Q3 | 1.15 Million AUD | 385.23% |
| 2020 FY | 1.15 Million AUD | 6.11% |
| 2020 Q1 | 485.61 Thousand AUD | -55.22% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 FY | 1.08 Million AUD | 0.0% |
| 2019 Q3 | 1.08 Million AUD | 0.0% |
| 2019 Q4 | 1.08 Million AUD | 0.0% |
| 2019 Q1 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2018 Q1 | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2018 Q3 | - AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2017 Q3 | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 Q1 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2016 Q1 | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 Q3 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2015 Q3 | - AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 Q1 | - AUD | 0.0% |
| 2014 Q3 | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2014 Q1 | - AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2013 Q1 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2006 FY | - AUD | 0.0% |
| 2006 Q4 | - AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| 4DMedical Limited | 4.17 Million AUD | 100.0% |
| Adherium Limited | - AUD | NaN% |
| Aroa Biosurgery Limited | 5.89 Million AUD | 100.0% |
| Atomo Diagnostics Limited | - AUD | NaN% |
| Anteris Technologies Ltd | 1.52 Million AUD | 100.0% |
| Control Bionics Limited | 336.16 Thousand AUD | 100.0% |
| Compumedics Limited | - AUD | NaN% |
| Cochlear Limited | 202.1 Million AUD | 100.0% |
| CleanSpace Holdings Limited | 2.76 Million AUD | 100.0% |
| Cyclopharm Limited | 4.01 Million AUD | 100.0% |
| EMVision Medical Devices Ltd | 1.76 Million AUD | 100.0% |
| Nova Eye Medical Limited | - AUD | NaN% |
| HeraMED Limited | - AUD | NaN% |
| Imricor Medical Systems, Inc. | 12.43 Million AUD | 100.0% |
| ImpediMed Limited | 810 Thousand AUD | 100.0% |
| InhaleRx Limited | - AUD | NaN% |
| LBT Innovations Limited | 1.74 Million AUD | 100.0% |
| Micro-X Limited | 65 Thousand AUD | 100.0% |
| Neurotech International Limited | - AUD | NaN% |
| OncoSil Medical Limited | - AUD | NaN% |
| PolyNovo Limited | 742 Thousand AUD | 100.0% |
| Respiri Limited | - AUD | NaN% |
| SomnoMed Limited | 709.07 Thousand AUD | 100.0% |
| Universal Biosensors, Inc. | 3.22 Million AUD | 100.0% |
| Uscom Limited | - AUD | NaN% |
| Visioneering Technologies, Inc. | - AUD | NaN% |